tiprankstipranks
Neumora Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe FlyNeumora Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
Neumora Therapeutics to host key opinion leader roundtable to discuss KORAs
Premium
The Fly
Neumora Therapeutics to host key opinion leader roundtable to discuss KORAs
3M ago
Neumora Therapeutics expects cash to fund operations into 2026
Premium
The Fly
Neumora Therapeutics expects cash to fund operations into 2026
4M ago
Neumora Therapeutics announces initiation of Phase 1b study of NMRA-511
PremiumThe FlyNeumora Therapeutics announces initiation of Phase 1b study of NMRA-511
5M ago
Neumora initiates Phase 2 study of navacaprant in bipolar depression
Premium
The Fly
Neumora initiates Phase 2 study of navacaprant in bipolar depression
6M ago
Neumora Therapeutics reports Q1 EPS (34c), consensus (34c)
Premium
The Fly
Neumora Therapeutics reports Q1 EPS (34c), consensus (34c)
7M ago
Neumora Therapeutics price target raised to $31 from $24 at RBC Capital
PremiumThe FlyNeumora Therapeutics price target raised to $31 from $24 at RBC Capital
9M ago
Neumora Therapeutics reports Q4 EPS (71c), consensus (55c)
Premium
The Fly
Neumora Therapeutics reports Q4 EPS (71c), consensus (55c)
9M ago
JPMorgan biotech analysts to hold an analyst/industry conference call
Premium
The Fly
JPMorgan biotech analysts to hold an analyst/industry conference call
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100